Free Trial

Inari Medical (NARI) Stock Price, News & Analysis

Inari Medical logo
$79.97 0.00 (0.00%)
As of 02/19/2025

About Inari Medical Stock (NASDAQ:NARI)

Key Stats

Today's Range
$79.97
$79.97
50-Day Range
$79.97
$79.97
52-Week Range
$39.76
$79.99
Volume
N/A
Average Volume
1.44 million shs
Market Capitalization
$4.68 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$69.22
Consensus Rating
Hold

Company Overview

Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

NARI Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Stryker concludes Inari Medical acquisition for $4.9bn
See More Headlines

NARI Stock Analysis - Frequently Asked Questions

Inari Medical's stock was trading at $51.05 at the start of the year. Since then, NARI shares have increased by 56.7% and is now trading at $79.97.

Inari Medical, Inc. (NASDAQ:NARI) issued its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of $0.01 by $0.09. The company's revenue for the quarter was up 22.5% compared to the same quarter last year.
Read the conference call transcript
.

Inari Medical (NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at a price of $14.00-$16.00 per share. BofA Securities and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers.

Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inari Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Tesla (TSLA), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
2/28/2024
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NARI
Fax
N/A
Employees
800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$69.22
High Stock Price Target
$80.00
Low Stock Price Target
$47.00
Potential Upside/Downside
-13.4%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
14 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.64 million
Pretax Margin
-9.29%

Debt

Sales & Book Value

Annual Sales
$493.63 million
Cash Flow
$0.09 per share
Price / Cash Flow
906.95
Book Value
$8.07 per share
Price / Book
9.91

Miscellaneous

Free Float
52,338,000
Market Cap
$4.68 billion
Optionable
Optionable
Beta
1.02
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:NARI) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners